| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2024-02-16 | EcoR1 Capital, LLC | iTeos Therapeutics, Inc. | 1,944,672 | 5.4% | EDGAR |
| SC 13G/A | 2024-02-14 | BIOTECHNOLOGY VALUE FUND L P | iTeos Therapeutics, Inc. | 671,726 | 1.9% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | iTeos Therapeutics, Inc. | 1,490,942 | 4.2% | EDGAR |
| SC 13G/A | 2024-01-23 | BlackRock Inc. | iTeos Therapeutics, Inc. | 4,261,745 | 11.9% | EDGAR |
| SC 13G/A | 2024-01-09 | MILLENNIUM MANAGEMENT LLC | iTeos Therapeutics, Inc. | 967,402 | 2.7% | EDGAR |
| SC 13G | 2023-10-24 | MILLENNIUM MANAGEMENT LLC | iTeos Therapeutics, Inc. | 2,090,833 | 5.8% | EDGAR |
| SC 13G/A | 2023-02-14 | RTW INVESTMENTS, LP | iTeos Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | BIOTECHNOLOGY VALUE FUND L P | iTeos Therapeutics, Inc. | 975,430 | 2.7% | EDGAR |
| SC 13G | 2023-02-09 | VANGUARD GROUP INC | iTeos Therapeutics, Inc. | 1,819,030 | 5.1% | EDGAR |
| SC 13G/A | 2023-01-26 | BlackRock Inc. | iTeos Therapeutics, Inc. | 4,479,421 | 12.6% | EDGAR |
| SC 13G/A | 2023-01-20 | BlackRock Inc. | iTeos Therapeutics, Inc. | 4,479,421 | 12.6% | EDGAR |
| SC 13G | 2022-07-08 | BlackRock Inc. | iTeos Therapeutics, Inc. | 3,721,237 | 10.5% | EDGAR |
| SC 13D/A | 2022-05-11 | Boxer Capital, LLC | iTeos Therapeutics, Inc. | 2,154,058 | 6.1% | EDGAR |
| SC 13G | 2022-05-02 | BIOTECHNOLOGY VALUE FUND L P | iTeos Therapeutics, Inc. | 1,041,669 | 2.9% | EDGAR |
| SC 13D/A | 2022-03-21 | Boxer Capital, LLC | iTeos Therapeutics, Inc. | 3,142,058 | 8.9% | EDGAR |
| SC 13G/A | 2022-02-14 | RTW INVESTMENTS, LP | iTeos Therapeutics, Inc. | 2,353,015 | 6.7% | EDGAR |
| SC 13G/A | 2022-02-10 | JANUS HENDERSON GROUP PLC | iTeos Therapeutics, Inc. | 3,533 | 0.0% | EDGAR |
| SC 13D/A | 2022-01-06 | Boxer Capital, LLC | iTeos Therapeutics, Inc. | 3,717,259 | 10.5% | EDGAR |
| SC 13D/A | 2021-12-10 | MPM BioVentures 2014, L.P. | iTeos Therapeutics, Inc. | 1,631,972 | 4.6% | EDGAR |
| SC 13D/A | 2021-10-19 | MPM BioVentures 2014, L.P. | iTeos Therapeutics, Inc. | 1,771,303 | 5.0% | EDGAR |